Signaling pathways essential for triple‐negative breast cancer stem‐like cells von Ehmsen, Sidse, Ditzel, Henrik J.

Volltext

Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome von Ehmsen, Sidse, Pedersen, Martin H., Wang, Guisong, Terp, Mikkel G., Arslanagic, Amina, Hood, Brian L., Conrads, Thomas P., Leth-Larsen, Rikke, Ditzel, Henrik J.

Volltext

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer von Alves, Carla L, Ditzel, Henrik J

Volltext

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy von Ma, Shijun, Zhao, Yue, Lee, Wee Chyan, Ong, Li-Teng, Lee, Puay Leng, Jiang, Zemin, Oguz, Gokce, Niu, Zhitong, Liu, Min, Goh, Jian Yuan, Wang, Wenyu, Bustos, Matias A., Ehmsen, Sidse, Ramasamy, Adaikalavan, Hoon, Dave S. B., Ditzel, Henrik J., Tan, Ern Yu, Chen, Qingfeng, Yu, Qiang

Volltext

HMGA2 as a Critical Regulator in Cancer Development von Mansoori, Behzad, Mohammadi, Ali, Ditzel, Henrik J., Duijf, Pascal H. G., Khaze, Vahid, Gjerstorff, Morten F., Baradaran, Behzad

Volltext

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer von Jacobsen, Kirstine, Bertran-Alamillo, Jordi, Molina, Miguel Angel, Teixidó, Cristina, Karachaliou, Niki, Pedersen, Martin Haar, Castellví, Josep, Garzón, Mónica, Codony-Servat, Carles, Codony-Servat, Jordi, Giménez-Capitán, Ana, Drozdowskyj, Ana, Viteri, Santiago, Larsen, Martin R., Lassen, Ulrik, Felip, Enriqueta, Bivona, Trever G., Ditzel, Henrik J., Rosell, Rafael

Volltext

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC von Chaib, Imane, Karachaliou, Niki, Pilotto, Sara, Codony Servat, Jordi, Cai, Xueting, Li, Xuefei, Drozdowskyj, Ana, Servat, Carles Codony, Yang, Jie, Hu, Chunping, Cardona, Andres Felipe, Vivanco, Guillermo Lopez, Vergnenegre, Alain, Sanchez, Jose Miguel, Provencio, Mariano, de Marinis, Filipo, Passaro, Antonio, Carcereny, Enric, Reguart, Noemi, Campelo, Charo Garcia, Teixido, Christina, Sperduti, Isabella, Rodriguez, Sonia, Lazzari, Chiara, Verlicchi, Alberto, de Aguirre, Itziar, Queralt, Cristina, Wei, Jia, Estrada, Roger, Puig de la Bellacasa, Raimon, Ramirez, Jose Luis, Jacobson, Kirstine, Ditzel, Henrik J, Santarpia, Mariacarmela, Viteri, Santiago, Molina, Migual Angel, Zhou, Caicun, Cao, Peng, Ma, Patrick C, Bivona, Trever G, Rosell, Rafael

Volltext

Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence von Goh, Jian Yuan, Feng, Min, Wang, Wenyu, Oguz, Gokce, Yatim, Siti Maryam J M, Lee, Puay Leng, Bao, Yi, Lim, Tse Hui, Wang, Panpan, Tam, Wai Leong, Kodahl, Annette R, Lyng, Maria B, Sarma, Suman, Lin, Selena Y, Lezhava, Alexander, Yap, Yoon Sim, Lim, Alvin S T, Hoon, Dave S B, Ditzel, Henrik J, Lee, Soo Chin, Tan, Ern Yu, Yu, Qiang

Volltext

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer von Alves, Carla L., Ehmsen, Sidse, Terp, Mikkel G., Portman, Neil, Tuttolomondo, Martina, Gammelgaard, Odd L., Hundebøl, Monique F., Kaminska, Kamila, Johansen, Lene E., Bak, Martin, Honeth, Gabriella, Bosch, Ana, Lim, Elgene, Ditzel, Henrik J.

Volltext

Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer von Skov, Natascha, Alves, Carla L., Ehmsen, Sidse, Ditzel, Henrik J.

Volltext

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy von Bao, Yi, Oguz, Gokce, Lee, Wee Chyan, Lee, Puay Leng, Ghosh, Kakaly, Li, Jiayao, Wang, Panpan, Lobie, Peter E., Ehmsen, Sidse, Ditzel, Henrik J., Wong, Andrea, Tan, Ern Yu, Lee, Soo Chin, Yu, Qiang

Volltext

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen rec... von Alves, Carla L, Elias, Daniel, Lyng, Maria B, Bak, Martin, Ditzel, Henrik J

Volltext

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells von Terp, Mikkel G, Olesen, Kristina A, Arnspang, Eva C, Lund, Rikke R, Lagerholm, B Christoffer, Ditzel, Henrik J, Leth-Larsen, Rikke

Volltext

Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery von Leth-Larsen, Rikke, Lund, Rikke R., Ditzel, Henrik J.

Volltext

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study von Kodahl, Annette R., Lyng, Maria B., Binder, Harald, Cold, Søren, Gravgaard, Karina, Knoop, Ann S., Ditzel, Henrik J.

Volltext

KeyPathwayMinerWeb: online multi-omics network enrichment von List, Markus, Alcaraz, Nicolas, Dissing-Hansen, Martin, Ditzel, Henrik J, Mollenhauer, Jan, Baumbach, Jan

Volltext

DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma von Wu, Qingqing, Luo, Xiaoyang, Terp, Mikkel G., Li, Qingrun, Li, Yuan, Shen, Lei, Chen, Ying, Jacobsen, Kirstine, Bivona, Trever G., Chen, Haiquan, Zeng, Rong, Ditzel, Henrik J.

Volltext

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study von Lyng, Maria B, Lænkholm, Anne-Vibeke, Søkilde, Rolf, Gravgaard, Karina H, Litman, Thomas, Ditzel, Henrik J

Volltext

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer von Kaminska, Kamila, Akrap, Nina, Staaf, Johan, Alves, Carla L., Ehinger, Anna, Ebbesson, Anna, Hedenfalk, Ingrid, Beumers, Lukas, Veerla, Srinivas, Harbst, Katja, Ehmsen, Sidse, Borgquist, Signe, Borg, Ake, Perez-Fidalgo, Alejandro, Ditzel, Henrik J., Bosch, Ana, Honeth, Gabriella

Volltext

Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors von Hubackova, Sona, Davidova, Eliska, Boukalova, Stepana, Kovarova, Jaromira, Bajzikova, Martina, Coelho, Ana, Terp, Mikkel G., Ditzel, Henrik J., Rohlena, Jakub, Neuzil, Jiri

Volltext